Cáncer de mama y osteoporosis

Jorge P. Suárez, William Onatra H., Jacinto A. Sánchez

Resumen


Se presenta un caso de una mujer de 54 años, con antecedentes de mastectomía izquierda por Ca. canalicular Estado III, con Osteoporosis O que no ha respondido a la terapia a base de calcio y fluor, proponiéndose la posibilidad de iniciar terapia hormonal de reemplazo.


Texto completo:

PDF

Referencias


Christiansen C., Riis B. "Post-menopausal Osteoporosis" Fagerstien 8, 2950 Vedback Dinamarca, 1990.

Overgaard R. " 'Effects of intranasal synthetic salmon calcitonin on bone breakdown" . Br. Med. J. 1989; 299:477.

Current Perspectives in the Management of the Menopausal and Postmenopausal patient. Symposium. Am. J. Obstet Gynecol 1987; 156: 1353.

Hodsman B., Drost D. "The response of vertebral bone mineral density during the treatment of .

Gambrell R.D. Use of progestogen therapy. A m. J. Obstet Gynecol. 1987; 156: 130-131.

Lobo R. , Singer M. "Depo-Medroxyprogester one Acetate compared with conjugated estrogens for the treatment of Post-menopausal women. Obstet Gynecol 1984; 63:1.

Fornander R, Rutqvist LE, Sjoberg HE, et al. Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women. J Clin Oncoll990; 8:1019-1024.

Love RR, Mazess RB, Tonney DC, et al. Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years. Breast Cancer Res Treat 1988; 12:279-302.

Barrett-Conner E, Bush TI. Estrogen replacement and coronary heart disease. Cardiovasc Clin 1989; 19:159-172.

Love RR, Newcomb PA, Weibe DA, et al. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. N Natl Cancer Inst 1990; 82 :1327-1 332.

Wile AG. DiSaia PJ . Hormones and breast cancer. Am J Surg 1989; 157: 438-442.

Dupont WD, Page DI. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991; 15 1:67-72.

Steimber KK, Thacker SB, Smith SS et all. A meta-anlysis of the effect of estrogen replacement therapy on the risk of breast cancer, JAMA 1991:266:1362- 1365.

Brener H, Engelsman B. Stegmaier C et all. Clinical Epidemiology of bilateral breast cancer. Cancer 1993; 72:3629-3635.

Wile AG, Opfell RW, Margilet DA. Hormone Replacement therapy in previously treatet breast cancer patients . Arn J Surg 1993; 165 :372-375.

Buller RE. Hormone rep replacement therapy following ginecologic cancer. Post graduate Obstet Gynecol 1993; 13:1-5.

Creasman WT. Hormone replacement therapy in breast cancer. Lancet 1993; 342: 1232.

Marchant DJ. Estrogen-replacement therapy in breast cancer. Cancer 1993; 7 1:2 169-2176.

Di Saia PJ. Hormone- replacement therapy in patients with breast cancer: a reappraisal. Cancer 1993 ; 71: J 490- 1500


comments powered by Disqus

Métricas de artículo

Cargando métricas ...

Metrics powered by PLOS ALM




Copyright (c) 2016 Revista Colombiana de Obstetricia y Ginecología

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

ISSN Impreso       0034-7434 

ISSN Electrónico   2463-0225

https://doi.org/10.18597/issn.0034-7434